West Harlem’s Volastra Therapeutics Appoints Charles Hugh-Jones As New CEO


The #1 source in the world for all things Harlem.

Volastra Therapeutics, a biotechnology company developing novel therapies to treat and prevent the formation of metastatic disease, has named Charles Hugh-Jones, MD, FRCP, as its Chief Executive Officer. Dr. Hugh-Jones Continue Reading →

The post West Harlem’s Volastra Therapeutics Appoints

Excerpt. This post was originally published on this site. Click here to read the post and view byline and photo credits etc.

You May Also Like

About the Author: harlemcondolife